What exactly is an ISO Class 7 cleanroom?
A cleanroom is a controlled environment designed to minimise contamination during sensitive manufacturing and assembly processes. The ISO Class 7 designation specifically relates to airborne particle concentrations, with ISO 14644-1:2015 specifying a maximum of 352,000 particles of 0.5 microns or larger, and just 2,930 particles of 5 microns or larger, per cubic metre of air.
For scale, a human hair is typically around 70 microns thick. What we're dealing with here are particles that can be more than 100 times smaller than this.
For invasive medical devices, particularly those designed to deliver therapies into sensitive areas of the body, such as the brain or eye, particulate and biological contamination can pose significant risks to both patient safety and device performance.
Even after terminal sterilisation, unwanted contamination introduced into these areas can potentially cause adverse biological responses, including inflammation and tissue reactions. Larger particles or fibres may also obstruct narrow fluid pathways, interfering with the delivery of a therapeutic.
HEPA filtration, controlled airflow and positive pressure help maintain the required airborne cleanliness, while appropriate monitoring and operating procedures support broader contamination control.

Our cleanroom is used primarily for device builds intended for critical testing, preclinical and early-stage clinical studies.
By completing these builds in-house, we gain valuable, first-hand manufacturing and assembly knowledge. Challenges with assembly sequences, joining methods and process repeatability can be quickly identified and addressed while the design is still in development, helping to reduce risk and uncertainty ahead of design transfer.
Jack Logan, one of our senior biomedical engineers, is the man charged with oversight of our cleanroom and can answer any further questions.
Thanks to Total Clean Air Limited for the installation of our modular cleanroom and for providing the team with training.




Comments